Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Birgit Salbach"'
Autor:
Ursula Eckstein-Mannsperger, Christoph Mundt, Benno Runnebaum, Manoshi Pakrasi, Niels Bergemann, Peter Parzer, Susanne Haisch, Birgit Salbach, Franz Resch, K. Klinga
Publikováno v:
Schizophrenia Research. 74:125-134
The expected therapeutic effect of estrogen as an adjunct treatment to antipsychotics in women suffering from schizophrenia for relapse prevention was to be tested under real-life conditions. A multicenter, randomized, placebo-controlled, double-blin
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6feba674f53ab6bc42769ffe1e4db967
https://doi.org/10.1016/j.schres.2004.12.009
https://doi.org/10.1016/j.schres.2004.12.009
Autor:
K. Klinga, Peter Parzer, Birgit Salbach, Benno Runnebaum, Franz Resch, Christoph Mundt, Iris Jannakos, Ines Nagl, Niels Bergemann
Publikováno v:
Schizophrenia Research. 73:357-366
Background Low estrogen levels leading to an elevated rate of menstrual dysfunctions such as amenorrhea and irregular menstruation have been described in women with schizophrenia and have often been attributed to antipsychotic-induced hyperprolactine
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1aa5ff7be2bcb7c7a5f509def3fd1ae8
https://doi.org/10.1016/j.schres.2004.06.013
https://doi.org/10.1016/j.schres.2004.06.013
Autor:
Birgit Salbach, Franz Resch, Peter Parzer, I. Nagl, Niels Bergemann, Benno Runnebaum, Ch. Mundt
Publikováno v:
Archives of Women's Mental Health. 5:119-126
The clinical observation of a possible relation between the phases of the menstrual cycle and psychotic illness dates well back to the beginning of the nineteenth century. This relation is considered to provide further evidence for the protective eff
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::afd4e31bc8ac5549acb973ec3b945501
https://doi.org/10.1007/s00737-002-0004-2
https://doi.org/10.1007/s00737-002-0004-2
Autor:
Malene Jensen, Peter Schönknecht, Johannes Schröder, Birgit Salbach, Johannes Pantel, K. Klinga, Tobias Hartmann
Publikováno v:
Neuroscience Letters. 307:122-124
Recent in-vitro studies indicate that estrogens such as 17beta-estradiol (E2) may decrease the production of beta-amyloid 1-42 (Abeta42), a peptide central for the formation of senile plaques in Alzheimer's disease (AD). To test this hypothesis in a
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ffe5b87b1be3e1160bae73528efedd07
https://doi.org/10.1016/s0304-3940(01)01896-1
https://doi.org/10.1016/s0304-3940(01)01896-1